期刊文献+

应用CGMS观察诺和锐30治疗T_2DM的血糖变异性 被引量:1

原文传递
导出
摘要 将41例口服降糖药控制差的T2DM患者(HbA1c>7.5%)随机分为诺和锐30组(治疗组)21例和诺和灵30R(对照组)20例,治疗至空腹血糖(FPG)、睡前血糖在目标范围后行动态血糖监测系统(CGMS)监测,分析两组血糖变异性。两组患者的平均血糖、FPG、睡前血糖无显著性差异(P>0.05),但两组最高血糖、最低血糖、血糖的标准差、低血糖发生率均有显著性差异(P<0.05)。结论诺和锐30较诺和灵30R治疗T2DM,血糖控制更理想,血糖变异性更小。
作者 袁杰 张丽
出处 《实用糖尿病杂志》 2010年第3期61-62,共2页 Journal of Practical Diabetology
  • 相关文献

参考文献5

二级参考文献7

  • 1Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther,2000,2:49-56. 被引量:1
  • 2Mastrototaro J. The MiniMed continuous glucose monitoring system(CGMS). J Pediatr Endocriol Metab, 1999,12:751-758. 被引量:1
  • 3Bode BW, Gross TM, Thornton KR, et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin. Diabetes Res Clin Pract, 1999,46:183-190. 被引量:1
  • 4Boyne MS, Silver DM, Kaplan J, et al. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes, 2003, 52:2790-2794. 被引量:1
  • 5Steil GM, Rebrin K, Mastrototaro J, et al. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther,2003,5:27-31. 被引量:1
  • 6Kaufman FR, Carpenter S, Gibson LC, et al. A pilot study of the continuous glucose monitoring system. Diabetes Care, 2001,24:2030-2034. 被引量:1
  • 7Rohlfing CL, England JD, Wiedmeyer HM, et al. Defining the relationship between plasma glucose and HbA1c. Diabetes Care, 2002,25:275-278. 被引量:1

共引文献129

同被引文献18

  • 1Schlichtkrull J,Munck O,Jersild M.The M-value,an index of blood sugur control in diabetics[J].Acta Med Scand,1965,177:95-102. 被引量:1
  • 2Service FJ,Molnar GD,Rosevear JW,et al.Mean amplitude of glycemic excursions,a measure of diabetic instability[J].Diabetes,1970,19(9):644-655. 被引量:1
  • 3Kovatchev BP,Clarke WL,Breton M,et al.Quantifying temporal glucose variability in diabetes via continuous glucose monitoring:mathematical methods and clinical application[J].Diabetes Technol Ther,2005,7(6):849-862. 被引量:1
  • 4Siegelaar SE,Holleman F,Hoekstra JB,et al.Glucose variability:does it Matter[J].Endocr rev,2010,31(2):171-182. 被引量:1
  • 5Monnier L Mas E,Ginet C,et al.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J],JAMA,2006,295:1681-1687. 被引量:1
  • 6Muggeo M,Zoppini G,Bonora E,et al.Fasting plasma glucose variabilily predicts 10-Year Survival of Type 2 Diabetic Patients:the Verona Diabetes Study[J].Diabetes Care,2000,23(1):45-50. 被引量:1
  • 7Gimeno-Orna JA,Castro-Alonso FJ,Boned-Juliani B,et al.Fasting plasma glucose variability as a risk factor of retinopathy in type 2 diabetic patients[J].J Diabetes Complications,2003,17(2):78-81. 被引量:1
  • 8The DECODE Study Group,The European diabetes epidemiology group.Glucose tolerance and cardiovascular mortality:comparison of fasting and 2-hour diagnostic criteria[J].Arch Intern Med,2001,12,161(3):397-405. 被引量:1
  • 9Bonora E.Postprandial peaks as a risk factor for cardiovascular disease:epidemiological perspectives[J],Int J Clin Pract Suppl,2002,129:5-11. 被引量:1
  • 10Shiraiwa T,Kaneto H,Miyatsuka T,et al.Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbAlc Diabetic Patients[J].Diabetes Care,2005,28(11):2806-2807. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部